PofoliaShared via Pofolia

Advanced Science· 2026Q1

Stimulation of OGG1 Enhances Oxidative DNA Damage Repair and Protects Against Acute Liver Failure by Acetaminophen

Zhao Zhenjun, Rahul Upadhyay, Alice Eddershaw, Chenchen Wang et al.

Short summary

A new small molecule, CMM-98, boosts the DNA repair enzyme OGG1's ability to process oxidative DNA damage by 57-fold, protecting against acetaminophen-induced acute liver failure in cell and animal models.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A novel small molecule, CMM-98, enhances the DNA repair enzyme OGG1's AP-site processing function.
  • CMM-98 increases OGG1's turnover of oxidative DNA lesions by 57-fold.
  • Treatment with CMM-98 reduced oxidative DNA damage burden in cellular and in vivo models of acetaminophen-induced liver failure.
  • CMM-98 ameliorated hepatocyte injury and protected against acute liver failure.

AI-generated from the title and abstract; the full text is not read.

Abstract

ABSTRACT Acetaminophen‐induced acute liver failure is characterized by reactive metabolite formation, resulting in profound oxidative stress and mitochondrial dysfunction, leading to oxidative DNA damage and loss of hepatocyte viability. While oxidative stress is well recognized as a central pathogenic driver, the contribution of DNA damage resolution pathways to hepatocyte survival remains poorly defined. Here we report the development of a small molecule, CMM‐98, that installs a robust AP‐site processing function in the DNA glycosylase OGG1 by binding the active site. Acting on the Schiff base intermediate, the molecule effectively rewires the enzyme's catalytic outcome under oxidative stress, boosting AP site turnover by 57‐fold. Using cellular and in vivo models of acetaminophen‐induced liver failure, we demonstrate that OGG1 catalysis manipulated by CMM‐98 reduces oxidative DNA damage burden, promotes the resolution of oxidative DNA lesions, and ameliorates hepatocyte injury. These findings identify DNA repair capacity as a modifiable determinant of acute liver injury outcome and establish chemical switching of OGG1 as a strategy to support hepatocyte resilience under extreme oxidative stress.

The authors' abstract, as published at the source. Advanced Science, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Pharmacology (Pharmacology, Toxicology and Pharmaceutics)

PharmacologyPharmacology, Toxicology and Pharmaceutics